Highlights + Updates

Highlights + Updates

Our CEO's perspective on Culmination Bio's funding
Our CEO's perspective on Culmination Bio's funding

Our Funding from Amgen Ventures and Merck GHI: Igniting Data-Driven Healthcare Research with Culmination Bio's Data Repository

The path to Culmination's vision
The path to Culmination's vision

Culmination is changing the world by becoming the trusted source for healthcare insights and discoveries to improve lives.

The power of multimodal data
The power of multimodal data

Culmination’s CEO, Dr. Lincoln Nadauld spoke at the Illumina Genomics Forum in San Diego about healthcare innovation.

Introducing our Head of Data
Introducing our Head of Data

Casey Frankenberger, PhD is Culmination's SVP, Head of Data, leading the development of our Intelligence Platform.

Culmination Bio raises 10M
Culmination Bio raises 10M

Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma.